Abortion is the process of ending a pregnancy by removing the embryo or fetus, as well as the placenta, from the uterus using drugs or surgery. Additionally, safe and successful abortion drugs include mifepristone and misoprostol. Additionally, progesterone hormone promotes healthy pregnancy growth, therefore its effects are blocked by the abortion drug mifepristone. The uterine lining degrades and the pregnancy is terminated when progesterone hormones are suppressed. Doctors also advise using misoprostol, which causes bleeding and discomfort, to empty the uterus after taking mifepristone. After taking misoprostol for 24 hours, the patient should see a doctor if bleeding does not occur.
Due to an increase in abortion rates among women worldwide, it is anticipated that the market for Abortion Drugs would grow significantly over the course of the projected period.
Key Companies in the Abortion Drugs Industry:
Corcept Therapeutics Inc.
Corcept Therapeutics Inc. was founded in 1998 and headquartered in California, United States. It operates internationally. Topline findings from a Phase 1b study evaluating Corcept Therapeutics Incorporated's proprietary cortisol modulator, miricorilant, in patients with suspected non-alcoholic steatohepatitis (NASH) were released in July 2023. Corcept Therapeutics Incorporated is a commercial-stage company that specializes in the discovery and development of drugs to treat severe endocrine, oncology, metabolism, and neurology disorders.
Danco Laboratories LLC
Danco Laboratories LLC is a pharmaceutical distributor, founded in 1971 and headquartered in New York, United States. It operates in the country. Mifeprex's manufacturer, Danco Laboratories, criticized a Texas judge's decision to prevent the Food and Drug Administration from approving pharmacological abortions in April 2023.
GenBioPro, Inc.
GenBioPro, Inc. was founded in and headquartered in Las Vegas, United States. It operates throughout the country. HEALTH AND SCIENCE In April 2023, the maker of abortion pills GenBioPro seeks a US court to maintain the availability of generic mifepristone.
